FYI Nurani On behalf of the RIPE CRISP team
Begin forwarded message:
Date: 27 maj 2015 11:48:32 CEST From: Izumi Okutani <izumi@nic.ad.jp> To: ianaxfer@nro.net Subject: Re: [NRO-IANAXFER] Reminder CRISP Team Meeting Wednesday May 27th 1:00 PM UTC
Dear Colleagues,
Please see below the agenda for the coming CRISP Team call today at UTC13:00 27th May. As usual, anyone is welcome to participate as an observer.
1. Agenda Review
2. Actions Review a. Notes from the last meeting b. Submission of comment to the CWG proposal
3. Community discussions a. RIPE, LACNIC meetings b. Others regions c. Global list d. Reconfirm the CRISP role in SLA discussions
4. SLA Review as the CRISP Team a. Feedback to the draft b. Confirm steps and time-line before submission
5. Follow up on CWG proposal a. Analysis of SLA exchange with ICANN/PTI b. Coordination on IPR
6. Agenda for NRO EC-CRISP meeting
7. Next Meeting
8. AOB
Regards, Izumi Okutani
On 2015/05/26 19:38, German Valdez wrote:
Webex information below.
German Valdez
=====
JOIN WEBEX MEETING https://ripencc.webex.com/ripencc/j.php?MTID=m88bfef1da7f02edbd7f2550e0883d6... <https://ripencc.webex.com/ripencc/j.php?MTID=m88bfef1da7f02edbd7f2550e0883d6a5> Meeting number: 707 107 621 <tel://707%20107%20621> Meeting password: crisp
JOIN BY PHONE 0800-051-3810 <tel://0800-051-3810> Call-in toll-free number (UK) +44-203-478-5289 <tel://+44-203-478-5289> Call-in toll number (UK) Access code: 707 107 621
Global call-in numbers: https://ripencc.webex.com/ripencc/globalcallin.php?serviceType=MC&ED=389532762&tollFree=1 <https://ripencc.webex.com/ripencc/globalcallin.php?serviceType=MC&ED=389532762&tollFree=1>
Toll-free dialing restrictions: http://www.webex.com/pdf/tollfree_restrictions.pdf <http://www.webex.com/pdf/tollfree_restrictions.pdf>
_______________________________________________ ianaxfer mailing list ianaxfer@nro.net https://www.nro.net/mailman/listinfo/ianaxfer
_______________________________________________ ianaxfer mailing list ianaxfer@nro.net https://www.nro.net/mailman/listinfo/ianaxfer